Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
AstraZeneca and The Medicines Company announce global collaboration in acute ischaemic heart disease
-
AstraZeneca to acquire Ardea Biosciences for $1 billion (net of existing cash) including lead product lesinurad in Phase III development for gout
-
FORXIGA (dapagliflozin) receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
-
AstraZeneca and Amgen announce collaboration to jointly develop and commercialise clinical-stage inflammation portfolio
-
US District Court finds SEROQUEL XR® formulation patent valid and infringed
-
US court denies preliminary injunction application against the FDA and dismisses AstraZeneca’s lawsuit without prejudice
-
UK court finds SEROQUEL XR® formulation patent invalid
-
Remaining TC-5214 Phase III efficacy studies do not meet endpoint, regulatory filing will not be pursued
-
AstraZeneca files lawsuit against the FDA for decision regarding quetiapine product labelling and exclusivity
-
FDA responds to AstraZeneca Citizen Petitions on quetiapine product labelling
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
